These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7603605)

  • 1. [Synthetic salmon calcitonin suppositories for the short-term treatment of involutive osteoporosis].
    Isaia GC; Di Stefano M; Sciolla A; Mussetta M; Vassellatti D
    Minerva Med; 1995 Mar; 86(3):101-4. PubMed ID: 7603605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis.
    Kollerup G; Hermann AP; Brixen K; Lindblad BE; Mosekilde L; Sørensen OH
    Calcif Tissue Int; 1994 Jan; 54(1):12-5. PubMed ID: 8118746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL; McTavish D
    Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.
    Ellerington MC; Hillard TC; Whitcroft SI; Marsh MS; Lees B; Banks LM; Whitehead MI; Stevenson JC
    Calcif Tissue Int; 1996 Jul; 59(1):6-11. PubMed ID: 8661976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss.
    Gennari C; Agnusdei D; Montagnani M; Gonnelli S; Civitelli R
    Calcif Tissue Int; 1992 Apr; 50(4):381-3. PubMed ID: 1571851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis.
    Thamsborg G; Jensen JE; Kollerup G; Hauge EM; Melsen F; Sorensen OH
    Bone; 1996 Feb; 18(2):207-12. PubMed ID: 8833216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
    Kopaliani M
    Georgian Med News; 2005 Apr; (121):38-42. PubMed ID: 15908722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women.
    Polatti F; Perotti F; Angelini GP; Vassellatti D; Rapisardi I
    Maturitas; 1993 Dec; 18(1):73-6. PubMed ID: 8107619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study.
    Lyritis GP; Ioannidis GV; Karachalios T; Roidis N; Kataxaki E; Papaioannou N; Kaloudis J; Galanos A
    Clin J Pain; 1999 Dec; 15(4):284-9. PubMed ID: 10617256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.
    Pontiroli AE; Pajetta E; Scaglia L; Rubinacci A; Resmini G; Arrigoni M; Pozza G
    Aging (Milano); 1994 Dec; 6(6):459-63. PubMed ID: 7748920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis].
    Abellán Pérez M; Bayina García FJ; Calabozo M; Carpintero Benítez P; Figueroa Pedrosa M; Fernández Crisóstomo C; García López A; García Pérez S; Mesa Ramos M; Paulino Tevar J
    An Med Interna; 1995 Jan; 12(1):12-6. PubMed ID: 7718710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal salmon calcitonin in postmenopausal osteoporosis: effect of different therapeutic regimens on vertebral and peripheral bone density.
    Perrone G; Galoppi P; Valente M; Capri O; D'Ubaldo C; Anelli G; Zichella L
    Gynecol Obstet Invest; 1992; 33(3):168-71. PubMed ID: 1612530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
    Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S
    Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K; Ravn P; Hansen MA; Christiansen C
    Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.